Overall THTX gets a fundamental rating of 3 out of 10. We evaluated THTX against 525 industry peers in the Biotechnology industry. While THTX is still in line with the averages on profitability rating, there are concerns on its financial health. THTX has a valuation in line with the averages, but it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year THTX has reported negative net income.
In the past year THTX had a positive cash flow from operations.
In the past 5 years THTX always reported negative net income.
In the past 5 years THTX reported 4 times negative operating cash flow.

1.2 Ratios

THTX has a better Return On Assets (-17.86%) than 79.10% of its industry peers.
With an excellent Return On Invested Capital value of 55.37%, THTX belongs to the best of the industry, outperforming 99.44% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-17.86%
ROE	N/A
ROIC	55.37%

ROA(3y)-32.34%

ROA(5y)-29.26%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

THTX's Operating Margin of 10.05% is amongst the best of the industry. THTX outperforms 92.35% of its industry peers.
Looking at the Gross Margin, with a value of 77.72%, THTX belongs to the top of the industry, outperforming 83.96% of the companies in the same industry.
In the last couple of years the Gross Margin of THTX has grown nicely.

		Industry Rank	Sector Rank
OM	10.05%
PM (TTM)	N/A
GM	77.72%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y4.54%

GM growth 5Y5.34%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

THTX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, THTX has about the same amount of shares outstanding.
The number of shares outstanding for THTX has been reduced compared to 5 years ago.
THTX has a worse debt/assets ratio than last year.

2.2 Solvency

THTX has an Altman-Z score of -8.27. This is a bad value and indicates that THTX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -8.27, THTX is not doing good in the industry: 70.15% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-8.27

ROIC/WACC4.64

WACC11.93%

2.3 Liquidity

A Current Ratio of 0.84 indicates that THTX may have some problems paying its short term obligations.
THTX has a worse Current ratio (0.84) than 89.37% of its industry peers.
THTX has a Quick Ratio of 0.84. This is a bad value and indicates that THTX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of THTX (0.65) is worse than 91.23% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.84
Quick Ratio	0.65

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for THTX have decreased by 0.00% in the last year.
THTX shows a small growth in Revenue. In the last year, the Revenue has grown by 2.19%.
THTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.31% yearly.

EPS 1Y (TTM)0%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-550%

Revenue 1Y (TTM)2.19%

Revenue growth 3Y7.14%

Revenue growth 5Y6.31%

Sales Q2Q%-19.48%

3.2 Future

THTX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.71% yearly.
Based on estimates for the next years, THTX will show a small growth in Revenue. The Revenue will grow by 3.44% on average per year.

EPS Next Y88.56%

EPS Next 2Y66.79%

EPS Next 3Y46.8%

EPS Next 5Y29.71%

Revenue Next Year-3.03%

Revenue Next 2Y5.03%

Revenue Next 3Y5.76%

Revenue Next 5Y3.44%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

THTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
THTX is valuated rather expensively with a Price/Forward Earnings ratio of 24.08.
THTX's Price/Forward Earnings ratio is rather cheap when compared to the industry. THTX is cheaper than 91.79% of the companies in the same industry.
THTX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.96.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	24.08

4.2 Price Multiples

94.22% of the companies in the same industry are more expensive than THTX, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	18.18

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
THTX's earnings are expected to grow with 46.80% in the coming years. This may justify a more expensive valuation.